
Ark Invest CEO & CIO Cathie Wood Talks Elon Musk's Massive Pay Package
Ark Invest CEO & CIO Cathie Wood is joined Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss investors disapproval of Elon's pay package. See omnystudio.com/listener for privacy information.
6 Nov 20255min

Former Kansas City Fed President Esther George Talks Federal Reserve
Former Kansas City Fed President Esther George is joined by Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the lack of consensus from within the Federal Reserve in recent days.See omnystudi...
6 Nov 20256min

EU's Dombrovskis Talks Ukraine Support, ESG Rule Pressure
The EU's Economy and Productivity Commissioner Valdis Dombrovskis discusses efforts to tap frozen Russian assets to support Ukraine, talks with China over rare earths and pressure over Europe's ESG ru...
6 Nov 202512min

Robinhood CEO Vlad Tenev Talks 3Q Earnings, Prediction Markets
Robinhood reported a third-quarter profit that beat Wall Street expectations but fell short on cryptocurrency revenue. CEO Vlad Tenev discusses the company's earnings, prediction markets, and the futu...
6 Nov 20258min

President & CEO of Charles Schwab Talks Advisor Services
President & CEO of Charles Schwab Rick Wurster discusses his first year, the investment environment, and advisor services being a critical driver of Schwab's business growth. Wurster spoke with Bloomb...
5 Nov 202514min

Khosla Ventures Co-Founder Talks Reevo
Khosla Ventures Co-Founder Vinod Khosla discusses backing AI-startup Reevo, the company's founder and CEO and founder David Zhu, and Reevo's "Frankenstack". Khosla spoke with Bloomberg's Ed Ludlow.See...
5 Nov 20259min

Apollo President Talks Credit Market
Apollo Global Management President Jim Zelter discusses the state of the credit market, and the investment into AI data centers. Zelter spoke with Bloomberg's Jonathan Ferro, Lisa Abramowicz and Annma...
5 Nov 20259min

Novo Nordisk CEO Mike Doustdar Talks Drug Sales
Novo Nordisk has cut its forecast for the fourth time this year, after disappointing sales of its blockbuster drugs Wegovy and Ozempic. It underscores the challenges facing its new chief executive Mik...
5 Nov 20256min





















